Hochschulschrift
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
XVIII, 127Seiten
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Ruperto-Carola University of Heidelberg, Dissertation, 2018
- Classification
-
Medizin, Gesundheit
Biowissenschaften, Biologie
- Keyword
-
Cancer immunotherapy
Bispecific T cell engager
Oncolytic virotherapy
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 11:40 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2018
Other Objects (12)
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Engineering targeted and cytokine-armed oncolytic measles viruses
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
Chemovirotherapy of malignant melanoma with a novel targeted and armed oncolytic measles virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Key parameters of measles virus production for oncolytic virotherapy
Chemovirotherapy employing Gemcitabine together with Oncolytic Measles Vaccine Viruses as a new Option for the Treatment of Pancreatic Cancer
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Engineering targeted and cytokine-armed oncolytic measles viruses
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
Chemovirotherapy of malignant melanoma with a novel targeted and armed oncolytic measles virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Key parameters of measles virus production for oncolytic virotherapy
Chemovirotherapy employing Gemcitabine together with Oncolytic Measles Vaccine Viruses as a new Option for the Treatment of Pancreatic Cancer
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Engineering targeted and cytokine-armed oncolytic measles viruses
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
Chemovirotherapy of malignant melanoma with a novel targeted and armed oncolytic measles virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Key parameters of measles virus production for oncolytic virotherapy
Chemovirotherapy employing Gemcitabine together with Oncolytic Measles Vaccine Viruses as a new Option for the Treatment of Pancreatic Cancer
Analysis of primary resistance phenomena to oncolytic measles vaccine virus